Nkarta announces treatment of first patient in first-in-human clinical trial of engineered nkg2d-based nk cell cancer immunotherapy nkx101

First multi-center clinical trial to investigate an engineered nk cell targeting nkg2d first multi-center clinical trial to investigate an engineered nk cell targeting nkg2d
NKTX Ratings Summary
NKTX Quant Ranking